Finds Arthritis A Barrier For Adults Seeking To Manage Diabetes
More than half of adults with diagnosed diabetes also have arthritis, a painful condition that can be a barrier to physical activity-an important health strategy for managing diabetes.
|
Trubion Initiates Study Of TRU-015 For Rheumatoid Arthritis Treatment
Wyeth Pharmaceuticals has commenced patient dosing in the next Phase 2b clinical trial of TRU-015 in patients with rheumatoid arthritis (RA).
|
Arthritis Is a Barrier To Activity For Diabetic Patients
Physical Activity is Vital for Successful Management of Both Arthritis and Diabetes.
|
May Is Arthritis Awareness Month
Today, one in five Americans suffers from the pain of arthritis.
|
Trubion Initiates Study Of SBI-087 For Rheumatoid Arthritis Treatment
Wyeth Pharmaceuticals has initiated a Phase 1 clinical trial of SBI-087, a next-generation drug candidate for the treatment of rheumatoid arthritis (RA).
|
Increased Out-Of-Pocket Expenses May Negatively Influence Arthritis Treatment
Study assessed the association between decline-to-fill rates as they relate to out-of-pocket expense for members initiating TNF-blocker therapy for the treatment of inflammatory conditions such as rheumatoid arthritis.
|
Pine Bark Naturally Reduces Osteoarthritis
More than 20 million Americans suffer from osteoarthritis, with half a million Americans having a total joint replacement each year.
|
HUMIRA Approved For Rheumatoid Arthritis Treatment
Abbott has received approval from the Japanese Ministry of Health, Labour and Welfare for HUMIRA for the treatment of rheumatoid arthritis in patients with inadequate response to conventional therapy.
|
ORENCIA Approved For Treatment Of Polyarticular Juvenile Idiopathic Arthritis
FDA has approved Bristol-Myers Squibb's ORENCIA for reducing signs and symptoms in pediatric patients six years and older with moderately to severely active polyarticular juvenile idiopathic arthritis.
|
Cod Oil Can Reduce Arthritis Drug Use
Cod liver oil can allow rheumatoid arthritis patients cut the use of non-steroidal anti-inflammatory drugs.
|
Rheumatoid arthritis sends many into early retirement
The highest cost in rheumatoid arthritis results from patients having to leave the workforce early due to the disease.
|
Top 10 Arthritis Advances Of 2007
The novel scaffold is porous, so the fabric can be seeded with cells and transplanted into a joint damaged by arthritis.
|
Myths About Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a complex, systemic inflammatory illness.
|
Genetic Connection Between Arthritis, Short Stature
Common genetic variants linked to arthritis may also play a role in human height.
|
Arthritis Burden Soaring
Arthritis is exploding in an aging population of US baby boomers and is projected to increase by 40% in the next two decades.
|
EUFLEXXA Is Effective In Treating Knee Osteoarthritis
Ferring Pharmaceuticals presented the results of two studies on the effectiveness of EUFLEXXA, an intra-articular hyaluronic acid for the relief of pain in knee osteoarthritis.
|
Study Uncovers Prevalence, Burden Of Pediatric Arthritis In US
About 294,000 U.S. children and teenagers under age 18 (or one in 250 children) have been diagnosed with arthritis or another rheumatologic condition.
|
Pine Bark Naturally Reduces Osteoarthritis Knee Pain
Affecting more than 10 million Americans, Osteoarthritis of the knee is one of the five leading causes of disability among the elderly.
|
Roche Submits FDA Application For ACTEMRA For Treatment Of Rheumatoid Arthritis
Roche submitted biologics license application to FDA seeking approval to market ACTEMRA to reduce the signs and symptoms in adults with moderate to severe rheumatoid arthritis.
|
Combining Medications Often Best Strategy To Battle Rheumatoid Arthritis
For patients with rheumatoid arthritis, combining one well-known, lower cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness
|
Researchers Identify New Variant Associated With Increased Risk For Rheumatoid Arthritis
Researchers carried out a genome-wide association study of nearly 400 individuals with rheumatoid arthritis and identified a novel variant on chromosome 6 that increases the risk for developing the disease.
|
Initiation Of DMARDS Is Significantly Delayed In Treatment Of Rheumatoid Arthritis
Initiation of disease-modifying antirheumatic drugs is significantly delayed despite guidelines that emphasize earlier and more aggressive treatment of rheumatoid arthritis.
|
Daily Activity Improved In Adults With Moderate To Severe Rheumatoid Arthritis After Treatment With
ORENCIA improved daily activity participation, such as work or household chores, physical and social-role independence and sleep quality in adult rheumatoid arthritis patients.
|
Data Demonstrate Efficacy, Safety With ORENCIA In Adults With Rheumatoid Arthritis
Bristol-Myers Squibb Company announced that cumulative data from a trial demonstrate the long-term efficacy and safety of ORENCIA in adult rheumatoid arthritis patients.
|
Use Of EUFLEXXA For Pain Relief In Patients With Knee Osteoarthritis Supported
Cost-utility study supports adoption of EUFLEXXA intra-articular hyaluronic acid for the relief of pain in patients with osteoarthritis of the knee.
|
Two Genes Linked To Disabling Arthritis Identified
A team of researchers has discovered two genes linked to a disabling form of arthritis called ankylosing spondylitis.
|
Mortality gap between rheumatoid arthritis patients and the general population
Life expectancy for rheumatoid arthritis patients has not improved over the past 4 decades.
|
Exercising In Water Reduces Osteoarthritis Pain
For patients suffering from osteoarthritis of the hip or knee, doing aerobic and stretching exercises in warm water can bring some relief from the pain and could improve daily function.
|
Arthritis Without Pain
"Arthritis Without Pain" offers practical advice for their use and explores the real-life experience of patients who take them.
|
How Gold Provides Treatment For Arthritis Pain
The gold easing arthritis pain discovery may renew interest in gold salts as a treatment for rheumatoid arthritis and other inflammatory diseases.
|
CDC Presents Data On Work Limitations Caused By Arthritis
Work limitation due to arthritis in all working-age adults ranges from a low of 3.4 percent in Hawaii to a high of 15 percent in Kentucky.
|
Benefit Lacking For Common Ways Of Treating Knee Osteoarthritis
Evidence of benefit is lacking for many common ways of treating osteoarthritis of the knee, including popular dietary supplement ingredients, a common surgical procedure, and injected preparations.
|
Researchers Identify Genes That Increase Rheumatoid Arthritis Risk
Researchers have identified a genetic region associated with increased risk of rheumatoid arthritis (RA).
|
Study Links High Volume Pain Pumps Following Arthroscopic Shoulder Surgery
Hundreds of individuals across the country use high volume pain pumps to cope with the pain that often follows arthroscopic shoulder surgery.
|
Consumers Should Not Use Asam Urat Flu Tulang, PJ Dewandaru For Arthritis Treatment
Health Canada advised the public not to use the health product Asam Urat Flu Tulang, PJ Dewandaru promoted to treat joint pain, rheumatism and arthritis.
|
Consumers Should Not Use Khun-Phra For Arthritis Treatment
Health Canada advised consumers not to use Khun-Phra promoted to treat arthritis and joint pain.
|
Meditation therapy for rheumatoid arthritis patients
For patients with rheumatoid arthritis under routine medical supervision, an 8-week meditation class plus a 4-month maintenance program had beneficial effects.
|
Artelon STT Spacer Increases Treatment Options For Thumb Arthritis
Small Bone Innovations's Artelon STT Spacer for early to mid-stage osteo-arthritis has been cleared by the FDA for marketing in the US.
|
Arthritis Patients Envolved In 'Walking On Pebbles' Research
More than 100 rheumatoid arthritis patients suffering from pain in the balls of their feet are to take part in new research at Leeds University.
|
Study Identifies Genetic Risk Factor For Rheumatoid Arthritis, Lupus
A genetic variation has been identified that increases the risk of two chronic, autoimmune inflammatory diseases: rheumatoid arthritis (RA) and systemic lupus erythematosus (lupus).
|
